Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Downregulated KLF2 in PV and ET May Induce Prothrombotic Gene Expression

Jihyun Song, PhD, Jahnavi Gollamudi, MD, Soo Jin Kim, MS, Radhika Gangaraju, MD, Tsewang Tashi, MD, Victor R. Gordeuk, MD, Perumal Thiagarajan, MD, Josef T. Prchal, MD

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-140852

Published: 2020

Journal Articles

Prior History of Venous Thromboembolism Is a Significant Risk Factor for Recurrence of Thrombosis after Cancer Diagnosis

Sargam Kapoor, MBBS, Aman Opneja, MBBS, Jahnavi Gollamudi, MD, Lalitha V. Nayak, MD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-141961

Published: 2020

Journal Articles

Venous Thromboembolism (VTE) in Sickle Cell Disease (SCD) Is Associated with Neutrophilia

Jahnavi Gollamudi, MD, Shashank Sarvepalli, MD, Tara Alin, APRN-CNP, Animesh Vadaparti, M.Binf, Jane A. Little, MD, Lalitha V. Nayak, MD

Blood (2019) 134 (Supplement_1): 791.

https://doi.org/10.1182/blood-2019-128855

Published: 2019

Journal Articles

Risk of Venous Thrombosis in Patients with Sickle Cell Trait after Orthopedic Surgery

Jahnavi Gollamudi, MD, Sadeer Al-Kindi, MD, Petra Martin, MD, Jane Little, MD, Lalitha V. Nayak, MD

Blood (2018) 132 (Supplement 1): 417.

https://doi.org/10.1182/blood-2018-99-114353

Published: 2018

Journal Articles

Safety of Apixaban in Patients with CKD Stage V and ESRD with Venous Thromboembolism

Jahnavi Gollamudi, MD, Sadeer Al-Kindi, MD, Petra Martin, MD, Lalitha V. Nayak, MD

Blood (2018) 132 (Supplement 1): 2523.

https://doi.org/10.1182/blood-2018-99-116251

Published: 2018

Journal Articles

Leukocyte Subtypes As Predictors for Venous Thromboembolism in Diffuse Large B-Cell Lymphoma

Jahnavi Gollamudi, MD, Gouri Dharmavaram, Petra Martin, MD, Kirsten Marie Boughan, DO, Brenda Cooper, MD, Molly M Gallogly, MDPhD, Ehsan Malek, MD, Leland Metheny, MD, Folashade Otegbeye, MBBChir,MPH, Benjamin K. Tomlinson, MD, Marcos de Lima, MD, Lalitha V. Nayak, MD, Paolo Caimi, MD

Blood (2018) 132 (Supplement 1): 495.

https://doi.org/10.1182/blood-2018-99-114225

Published: 2018

NARROW

Downregulated KLF2 in PV and ET May Induce Prothrombotic Gene Expression

Prior History of Venous Thromboembolism Is a Significant Risk Factor for Recurrence of Thrombosis after Cancer Diagnosis

Venous Thromboembolism (VTE) in Sickle Cell Disease (SCD) Is Associated with Neutrophilia

Risk of Venous Thrombosis in Patients with Sickle Cell Trait after Orthopedic Surgery

Safety of Apixaban in Patients with CKD Stage V and ESRD with Venous Thromboembolism

Leukocyte Subtypes As Predictors for Venous Thromboembolism in Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Downregulated KLF2 in PV and ET May Induce Prothrombotic Gene Expression

Prior History of Venous Thromboembolism Is a Significant Risk Factor for Recurrence of Thrombosis after Cancer Diagnosis

Venous Thromboembolism (VTE) in Sickle Cell Disease (SCD) Is Associated with Neutrophilia

Risk of Venous Thrombosis in Patients with Sickle Cell Trait after Orthopedic Surgery

Safety of Apixaban in Patients with CKD Stage V and ESRD with Venous Thromboembolism

Leukocyte Subtypes As Predictors for Venous Thromboembolism in Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only